Clinical Research Directory
Browse clinical research sites, groups, and studies.
Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy
Sponsor: R-Bio
Summary
This clinical trial is conducted to assess the long-term safety of "jointstem" in patients with degenerative knee arthritis who participated in the previous BS-JS-IIT1 investigator initiated trial.
Official title: Long-Term Extension Study of Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy in Patients With K-L Grade III Knee Osteoarthritis After 『JOINTSTEM』 Administration
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2023-12-01
Completion Date
2029-12-31
Last Updated
2022-09-28
Healthy Volunteers
No
Conditions
Interventions
JOINTSTEM
JOINTSTEM is an OA treatment that uses autologous adipose-derived mesenchymal stem cells. As it does not use allogenic tissues and is incubated without additional genetic modification or mechanical and chemical modification through differentiation, it is classified as 'autologous cell therapy' and is completely free of immunologic rejection.